← Eichor
Study identifier: NCT03547232 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)

Condition: Acute Pancreatitis · Complication · Mortality Rate  ·  Sponsor: Peking Union Medical College Hospital

PhasePhase 4
Planned participants1504
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Acute pancreatitis (AP) is an inflammatory condition of the pancreas following the activated pancreatic enzymes induced by varied causes, with or without other organ(s) dysfunction. The production and release of inflammatory factors is generally considered as the key factor of pathogenesis. Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly applied agents for inflammatory diseases. A series studies have proved that indomethacin can reduce the risk of post-endoscopic retrograde cholangiopancreatography (ERCP), but high-quality evidence is still lacking in the field of effectiveness of NSAIDs to treat, rather than prevent, other types of AP. Majority of animal experiments showed that NSAIDs had protective effects for organ functions, but the results of several preliminary clinical studies were inconsistent. Randomized controlled trials are eagerly awaited to elucidate its effects on AP.

This description comes directly from the study's public registry record.

Talk to the study team

Dong Wu, M.D.  ·  8618612671010  ·  dongwu@pumc.edu.cn

Always discuss trial participation with your own doctor first.

Locations (17)

Peking University Sixth HospitalBeijing, Beijing Municipality, ChinaRecruiting
Peking Union Medical College HospitalBeijing, Beijing Municipality, ChinaRecruiting
Liangxiang HospitalBeijing, Beijing Municipality, ChinaRecruiting
Guiyang Second People's HospitalGuiyang, Guizhou, ChinaRecruiting
Baoding Seventh HospitalBaoding, Hebei, ChinaRecruiting
Fourth Affiliated Hospital of Harbin Medical UniversityHarbin, Heilongjiang, ChinaRecruiting
Dengzhou People's HospitalDengzhou, Henan, ChinaRecruiting
Second People Hospital of NanyangNanyang, Henan, ChinaRecruiting
The Second People's Hospital of Huai'anHuaian, Jiangsu, ChinaRecruiting
Nantong First People's HospitalNantong, Jiangsu, ChinaRecruiting
Suqian People's HospitalSuqian, Jiangsu, ChinaRecruiting
Wuxi Third People's HospitalWuxi, Jiangsu, ChinaRecruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03547232